ATBPF
Price:
$0.216
Market Cap:
$16.01M
Antibe Therapeutics Inc., a biotechnology company, engages in developing novel therapeutics and medical devices in the areas of pain, inflammation and regenerative medicine in Canada, Europe, the United States, and internationally. The company's drugs are designed to prevent the gastrointestinal damage and bleeding caused by non-steroidal anti-inflammatory drugs. Its lead compound is Otenaproxesul, a hydrogen sulfide-releasing derivative of naproxen for treating post-operative pain, migraine, dysmenorrhea, traumatic injury, dental pain, and gout that has completed Phase 2B gastrointestinal safety study. In addition, the company's products comprise ATB-352, which is in preclinical stage for a...[Read more]
Industry
Medical - Devices
IPO Date
2014-10-09
Stock Exchange
PNK
Ticker
ATBPF
According to Antibe Therapeutics Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 4.67M. This represents a change of -80.89% compared to the average of 24.43M of the last 4 quarters.
The mean historical Enterprise Value of Antibe Therapeutics Inc. over the last ten years is 19.56M. The current 4.67M Enterprise Value has changed 2.29% with respect to the historical average. Over the past ten years (40 quarters), ATBPF's Enterprise Value was at its highest in in the March 2021 quarter at 138.91M. The Enterprise Value was at its lowest in in the December 2021 quarter at -24705057.46.
Average
19.56M
Median
7.77M
Minimum
2.41M
Maximum
117.78M
Discovering the peaks and valleys of Antibe Therapeutics Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 870.85%
Maximum Annual Enterprise Value = 117.78M
Minimum Annual Increase = -95.33%
Minimum Annual Enterprise Value = 2.41M
Year | Enterprise Value | Change |
---|---|---|
2023 | 24.29M | 341.20% |
2022 | 5.51M | -95.33% |
2021 | 117.78M | 870.85% |
2020 | 12.13M | 377.98% |
2019 | 2.54M | -45.47% |
2018 | 4.65M | 10.30% |
2017 | 4.22M | -64.87% |
2016 | 12.01M | 397.77% |
2015 | 2.41M | -75.96% |
2014 | 10.04M | -23.95% |
The current Enterprise Value of Antibe Therapeutics Inc. (ATBPF) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
49.19M
5-year avg
32.45M
10-year avg
19.56M
Antibe Therapeutics Inc.’s Enterprise Value is less than Biotron Limited (16.98M), greater than Bioasis Technologies Inc. (397.14K), less than Covalon Technologies Ltd. (93.17M), less than Mosaic ImmunoEngineering Inc. (8.29M), less than Ceapro Inc. (16.01M), less than Cellectis S.A. (115.55M), less than Adynxx, Inc. (0), greater than AVAX Technologies, Inc. (581.00), greater than BioCardia, Inc. (-5896313.00), less than Adial Pharmaceuticals, Inc. WT EXP 073123 (6.48M), greater than null (1.27M),
Company | Enterprise Value | Market cap |
---|---|---|
16.98M | $11.30M | |
397.14K | $284.08K | |
93.17M | $72.60M | |
8.29M | $7.24M | |
16.01M | $13.31M | |
115.55M | $183.12M | |
0 | $581.00 | |
581.00 | $6.89K | |
-5896313.00 | $10.12K | |
6.48M | $0 | |
1.27M | $0 |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Antibe Therapeutics Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Antibe Therapeutics Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Antibe Therapeutics Inc.'s Enterprise Value?
What is the highest Enterprise Value for Antibe Therapeutics Inc. (ATBPF)?
What is the 3-year average Enterprise Value for Antibe Therapeutics Inc. (ATBPF)?
What is the 5-year average Enterprise Value for Antibe Therapeutics Inc. (ATBPF)?
How does the current Enterprise Value for Antibe Therapeutics Inc. (ATBPF) compare to its historical average?